Metastasis-associated lung adenocarcinoma transcript 1 (malat1) is an oncogenic long non-coding RNA (lncRNA) which has been proven to be associated with various types of tumors. Transcription factor specificity protein 1 (SP1) is overexpressed in many types of cancers. Previously, we observed that malat1 expression level is regulated by SP1 in lung cancer. In the present study, we found that transfection of expression construct of malat1 5 0 end fragment M5 enhances stability and transcriptional activity of SP1. Various SP1 target genes are also upregulated following overexpression of malat1 M5 in lung adenocarcinoma cells. We also showed that malat1 M5 interacts with the C-terminal domain of SP1 by RNA immunoprecipitation (RIP) assay coupled with UV cross-linking. Malat1-SP1 association results in increase of SP1 stability. In turn, SP1 promotes malat1 transcription, thus forming a positive feedback loop. In conclusion, our data show that in lung adenocarcinoma cells, malat1 interacts with SP1 protein and promotes SP1-mediated transcriptional regulation of SP1 target genes.
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| INTRODUCTION
Metastasis-associated lung adenocarcinoma transcript 1 (malat1) is a well-conserved long non-coding RNA (lncRNA) implicated in diseases including cancer. It was first recognized as a prognostic parameter for patient survival in stage I lung cancer and later shown to be upregulated in multiple human cancer tissues. Elevated expression of malat1 has been associated with hyperproliferation, metastasis, and poor prognosis. [1] [2] [3] [4] [5] Transcription factor specificity protein 1 (SP1) is the original member of the Sp transcription factor family. 6 Sp factors contain C2H2-type zinc fingers and preferentially bind GC boxes. Although often described as a general transcription factor, SP1-dependent transcription is highly regulated throughout development, cellular differentiation and tumorigenesis. 6 SP1 is overexpressed in many cancers, including breast, gastric, pancreatic, lung and thyroid cancers. [7] [8] [9] [10] In patient specimens, SP1 levels correlated with stage, invasive potential, metastasis, poor prognosis and patient survival rate in almost all cancers. On this basis, targeting SP1 in cancer treatment has been suggested.
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Previously, we found that SP1 regulated malat1 transcription to promote tumor metastasis of lung cancer. 14 However, the detailed mechanism of malat1 function remains obscure. To obtain a deeper Shufeng Li and Fang Ma contributed equally to this study.
understanding of the effect of malat1 and show how lncRNA malat1
confers an oncogenic function in lung cancer, the present study was designed to evaluate the role of malat1 in lung adenocarcinoma cells.
In this study, we found that in malat1 transfected adenocarcinoma A549 and H1299 cells, SP1 is upregulated compared with non-transfected cells. We seek to determine the underlying molecular mechanisms by which malat1 regulated downstream effectors in lung adenocarcinoma.
| MATERIALS AND METHODS

| Patients and tumor samples
Twenty-five lung adenocarcinoma tissues and paired distant nontumor lung tissues were randomly selected from surgical specimens at the Affiliated Drum Tower Hospital of Nanjing University Medical School (Nanjing, China). Written informed consent was obtained from all the patients. All specimens were snapfrozen in liquid nitrogen after excision. Clinicopathological characteristics of the patients included in this study were collected and are provided in Table 1 .
The current study was approved by the Ethics Committee of Southeast University.
| Plasmids and reagents
The malat1 fragment M1-M5(NR_002819.2) was cloned into the pcDNA vector ( Figure 1A ). pGMSP1-Luc (SP1 luciferase reporter plasmid containing SP1-responsive element) was from Yeasen Company (China). Validated duplex siRNAs for malat1 were purchased from Sigma Chemical Co. (St Louis, MO, USA). 15 Control non-silencing siRNA also was purchased from Sigma.
| RT-PCR and RT-qPCR analysis
Total RNA was extracted from cells or tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's instructions. Reverse transcriptase kit (TaKaRa Bio, Kusatsu, Japan) was used for cDNA synthesis. qPCR was carried out with a SYBR-Green Premix Ex Taq (Roche, Basel, Switzerland). GAPDH mRNA was used as an internal control. Primer sequences are available upon request. Each experiment was done in triplicate. Relative expression was calculated using the comparative threshold (CT) method.
| Western blot
Total cell protein was extracted and western blotting was carried out as previously described. 14 The primary antibodies anti-SP1 
| Wound-healing assay
Wound-healing assay was carried out as previously described. 
| Transwell assay
Transwell assay was done using Boyden chambers containing Transwell membrane filter inserts with 8-lm pore size as previously described. 14 experiments AE SD,*P < .05. C, CCK-8 test was carried out after cell transfection with si-control, or si-malat1. P < .01. D, Tumor growth curves indicate that malat1 siRNA injection treatment significantly inhibited A549 xenograft tumor growth whereas A549 cells transfected with pcDNA encoding the malat1 M5 fragment grew faster. *P < .01 sample buffer, electrophoresed on 12% SDS-PAGE and detected using standard western blot analysis.
| Animals
Athymic nude mice (6-8 weeks of age) were obtained from Shanghai Laboratory Animal Center (Shanghai, China) and housed under germfree conditions. Animal welfare and experimental procedures were carried out strictly in accordance with high standard animal welfare and other related ethical regulations approved by Southeast University.
| Subcutaneous tumor model
Subcutaneous tumor model was carried out as previously described. F I G U R E 2 Metastasis-associated lung adenocarcinoma transcript 1 (malat1) fragment M5 has an important function in the migration and invasion of lung cancer A549 cells and H1299 cells. A, malat1 M5 fragment promoted cell invasion and migration, whereas knockdown of malat1 resulted in a marked inhibition of cell invasion and migration as determined by Transwell assays. A549 and H1299 cells were transfected with plasmid pcDNA as a control or pcDNA encoding the malat1 M5 fragment or control siRNA or malat1 siRNA. A-1, Representative membranes stained with Giemsa are shown. Scale bar 100 lm. A-2, Quantitative analysis of the number of the cells that migrated to the lower side of the membrane. Data are mean AE SD of 3 independent experiments.***P < .01 vs control. B, Wound-healing assay was used to detect A549 cell motility changes after silencing malat1 by malat1 RNAi or overexpressing malat1 M5 fragment, then wound-healing scratch motility assays were carried out. B-1, Cell migration was assessed at 0 and 24 h. Representative images are shown. B-2, Statistical analysis of wound closure. Gap size at 0 h was set to 100% and percentage of closed wound was calculated at 24 h (n = 3; ***P < .01) 16 Briefly, the FITC labelled malat1 probe was pur- Finally, the slides were viewed using a laser scanning confocal microscope.
3 | RESULTS 3.1 | Overexpression of the malat1 fragment M5 in lung adenocarcinoma cells significantly increases proliferation Figure 1D ). Taken together, these data indicated that the malat1 M5 fragment has evident promotional effects on cell growth.
| Overexpression of the malat1 M5 fragment in lung adenocarcinoma cells significantly increases metastasis
Next, the fuctional consequence of malat1 M5 on cell invasion was investigated. Transwell assays indicated that overexpression of the malat1 M5 fragment increased invasion, whereas si-malat1 inhibited the invasion (Figure 2A ). Wound-healing results showed that M5-overexpressed A549 cells and H1299 cells migrated faster whereas knockdown of malat1 noticeably impaired cell migration ( Figure 2B ).
These results indicated that the malat1 M5 RNA fragment, indeed, functions in cell migration and invasion.
| Transfection of M5 expression construct enhances transcriptional activity of SP1
Our previous studies have shown that upregulation of malat1 was mediated by the transcription factor SP1 in cancer cells, and that downregulation of malat1 or SP1 expression by RNAi both reduce tumor migration. 14 In present study, we attempted to determine how malat1 M5 promotes cell viability and migration. Interestingly, we found that overexpression of malat1 M5 led to an increased level of SP1 protein whereas downregulation of malat1 by RNAi decreased SP1 expression level in A549 and H1299 cells ( Figure 3A , B). As SP1 is a transcription factor, the most significant function of SP1 is to regulate many target genes. To investigate whether SP1
target genes were also affected by malat1, we further examined protein levels of vascular endothelial growth factor (VEGF) and urokinase-type plasminogen activator receptor (uPAR) in cells after transfection of malat1 M5 expression construct, as VEGF, uPAR as well as SP1 itself, are well known target genes of SP1. [18] [19] [20] As shown in Figure 3B , expression of VEGF and uPAR was increased F I G U R E 3 Metastasis-associated lung adenocarcinoma transcript 1 (malat1) M5 regulated the expression of specificity protein 1 (SP1) and SP1 target genes. A, malat1 siRNA significantly downregulated SP1 in A549 and H1299 cells, whereas overexpression of malat1 M5 caused accumulation of SP1 determined by immunofluorescence staining. Scale bar, 10 lm. B, After 48 h of transfection with pcDNA-M5, blank vector pcDNA, si-malat1 or si-control in A549 and H1299 cells, total RNAs and protein, respectively, were collected, then (B-1) RT-PCR and (B-2) western blotting were carried out to detect the levels of SP1,vascular endothelial growth factor (VEGF) and urokinase-type plasminogen activator receptor (uPAR). GAPDH was used as control. B-3, Relative density of SP1, VEGF and uPAR was plotted (relative to corresponding control) normalized to GAPDH AE SD from 3 independent experiments. ***P < .01. C, Analysis of luciferase intensity in cells cotransfected with pcDNA-M5, blank vector pcDNA, si-malat1 or si-control, then with SP1-Luc and the Renilla luciferase reporter plasmid. After 24 h of transfection, cells were assayed using a Dual-Luciferase Reporter Assay System kit (Promega, Madison, WI, USA). All results are from 3 independent experiments. Values are mean AE SD, ***P < .01 compared with values from cells transfected with control sequence of human SP1 contains 785 amino acids ( Figure 5A ). SP1
has N-terminal transactivation domains characterized by glutaminerich regions, a middle region with highly charged amino acid residues and a C-terminus containing a zinc finger protein motif, by which it binds directly to DNA and enhances gene transcription. To investigate whether malat1 M5 RNA could interact with SP1 protein and which domain of SP1 is responsible for their interaction, we overexpressed full-length SP1 and SP1 N-terminus in A549 cells, then RNA-protein pull-down assays were carried out. As shown in Fig- ure 5B, digoxin-labeled malat1 M5 RNA can bind to full-length SP1
but not to the SP1 N-terminus. To further identify whether the Cterminal domain of SP1 is necessary for interacting with lncRNA malat1 M5, UV cross-linking assay was carried out, and the result confirmed that the C-terminal DNA-binding domain of SP1 was responsible for direct association with malat1 M5 ( Figure 5C ). RNA immunoprecipitation experiment using SP1 antibody followed by quantitative real-time PCR for malat1 in A549 cells was also carried out, and the results showed that antibody against SP1 could result in higher enrichment of malat1 RNA compared with the IgG control ( Figure 5D ). In summary, results of in vitro UV cross-linking assay and in vivo RIP indicated specific interaction between SP1 and malat1. The malat1 M5 fragment can directly bind with the SP1 Cterminal DNA binding domain.
| Malat1 level is significantly correlated with SP1 in lung adenocarcinoma patients
To assay the expression levels of malat1 and SP1 in lung adenocarcinoma specimens, we detected 25 pairs of lung adenocarcinoma tissues and adjacent non-tumor tissues (Table 1) . RT-qPCR results indicated that malat1 was significantly upregulated in tumor samples compared with the adjacent non-tumoral samples ( Figure 6A ). Similar to a previous report, 24 we observed that SP1 mRNA expression was also significantly higher in lung adenocarcinoma compared with normal tissues( Figure 6A ). RT-qPCR of patient specimens showed a positive correlation between malat1 and SP1 expression in human lung adenocarcinoma tissues. Immunohistochemistry was carried out to detect SP1 protein expression in lung cancer tissues and adjacent normal tissues. SP1 staining was higher in human malignant compared to non-malignant tissues ( Figure 6B ; Table 2 ). In addition,
RNA-FISH and protein immunofluorescence assay also confirmed that both SP1 and malat1 were highly expressed in lung Malat1 is an 8000 nucleotide-long macromolecule that can form a complex structure to recruit many different protein factors for interacts with SP1 through the zinc-finger domain.
As suggested by early publications, 6,29 SP1 is highly regulated by post-translational modification, including phosphorylation, sumoylation, and ubiquitylation, and is targeted to proteasome-mediated degradation pathways. Normally, half-life of SP1 is short according to ubiquitin-mediated proteasomal degradation. 30 We observed that and 732. 31 Herein, we identified that the C-terminus of SP1 was also responsible for direct association with malat1 M5, so it is possible that malat1 stabilizes SP1 through inhibiting the interaction of b-TCRP with SP1 or inhibiting the phosphorylation of SP1 on threonine 739 or 728 and 732, therefore blocking SP1 ubiquitination and degradation. In addition, the relationship between lncRNA malat1, protein SP1 and chromatin remains to be elucidated. We speculate that this is a dynamic process in cells. We propose a hypothesis that the association of SP1 and malat1 forms a complex to enhance the stability of SP1 and that the malat1-SP1 compound is recruited to the specific target gene, then malat1 dissociates and SP1 starts to activate the target gene. Moreover, how lncRNAs control gene expression and the molecular function archetypes of lncRNAs have recently been studied. LncRNAs have various important regulatory effects on target gene expression by contributing to epigenetic modification, transcription and post-transcriptional processing through specific interactions with proteins and other cellular factors. [32] [33] [34] This type of association between a transcription factor and lncRNA is not the first such discovery; similar to our report, previous studies have found that lncRNA MEG3 can interact with the transcription factor p53 and increase the activity of p53. 27, 35, 36 In summary, in A549 and H1299 cells, overexpression of malat1 increased SP1 stability. In turn, SP1 transcriptionally regulated malat1, thus forming a positive feedback loop and promoted SP1 target gene expression, which was involved in malignant transformation and carcinogenesis ( Figure 7 ). These findings indicate an important mechanism of the malat1-SP1 loop involving reciprocal regulation between malat1 and SP1. Our work shows that malat1
confers an oncogenic function and may provide a new strategy for treatment of lung adenocarcinoma. F I G U R E 7 Schematic diagram illustrating that metastasisassociated lung adenocarcinoma transcript 1 (malat1) and specificity protein 1 (SP1) form a complex, ultimately affecting transcription of SP1 target genes. uPAR, urokinase-type plasminogen activator receptor; VEGF, vascular endothelial growth factor
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